Medicines / Ranbaxy Laboratories / Synriam
SynriamArterolane + Piperaquine
Synriam is marketed by Ranbaxy Laboratories. 2 packs on NPPA's price list for July 2026, containing Arterolane + Piperaquine.
- Packs listed
- 2
- Lowest MRP
- ₹75.00
- Per unit
- ₹25.00 to ₹96.33
- Price-controlled packs
- 0 of 2
- Dosage forms
- 2
Packs and prices
- ₹289.00Synriam 150/750 mg Tablet 3Arterolane + Piperaquine Tablet 150/750 mg · ₹96.33 per tablet
- ₹75.00Synriam 37.5/187.5 mg Tablet DT 3Arterolane + Piperaquine Tablet DT 37.5/187.5 mg · ₹25.00 per tablet
The company
Ranbaxy Laboratories has 2,345 packs on the price list, and CDSCO has named it as the manufacturer of 24 failed batches since Sep 2017. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.